From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugsRebecca L. McIntyre, Georges E. Janssens|EMBO Molecular Medicine|2019Cited by 118
HDAC1/2 inhibitor therapy improves multiple organ systems in aged miceAlessandra Tammaro, Georges E. Janssens|iScience|2023Cited by 12
Plasma triacylglycerol length and saturation level mark healthy aging groups in humansWeisha Li, Georges E. Janssens|GeroScience|2024Cited by 2